These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32591288)

  • 1. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL
    Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.
    Ghanem IAE; Abdullatif TM; Hassanin O
    Avian Pathol; 2023 Aug; 52(4):251-263. PubMed ID: 37158499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination.
    Becerra R; Maekawa D; García M
    Avian Dis; 2023 Jun; 67(2):145-152. PubMed ID: 37556293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain.
    El Khantour A; Darkaoui S; Tatár-Kis T; Mató T; Essalah-Bennani A; Cazaban C; Palya V
    Avian Dis; 2017 Sep; 61(3):378-386. PubMed ID: 28957008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Efficacy of Recombinant Newcastle Disease Virus Vaccines (Double-Insert vHVT-IBD-ND and Single-Insert vHVT-ND) Followed by a Vaccination with a Live Newcastle Disease Vaccine Against a Moroccan Velogenic Newcastle Disease Challenge in Commercial Broilers.
    Fellahi S; Rawi T; Fagrach A; Berrada L; Delvecchio A; Touzani CD; Houadfi ME; Kichou F; Lemiere S
    Avian Dis; 2022 Dec; 66(4):396-403. PubMed ID: 36715470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and immune efficacy of a recombinant turkey herpesvirus vaccine strain expressing fusion protein of genotype VII Newcastle disease virus.
    Jia W; Zhang X; Wang H; Teng Q; Xue J; Zhang G
    Vet Microbiol; 2022 May; 268():109429. PubMed ID: 35421830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.
    Palya V; Tatár-Kis T; Mató T; Felföldi B; Kovács E; Gardin Y
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):105-15. PubMed ID: 24368086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
    Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
    Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine.
    Rauw F; Gardin Y; Palya V; van den Berg T; Lambrecht B
    Avian Pathol; 2014; 43(1):26-36. PubMed ID: 24283258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses.
    Criado MF; Kassa A; Bertran K; Kwon JH; Sá E Silva M; Killmaster L; Ross TM; Mebatsion T; Swayne DE
    Vaccine; 2023 May; 41(18):2893-2904. PubMed ID: 37012117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age.
    Gelb J; Jackwood DJ; Brannick EM; Ladman BS
    Avian Dis; 2016 Sep; 60(3):603-12. PubMed ID: 27610719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.